Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Tph cells are linked to the severity of systemic lupus erythematosus.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Tofacitinib is an effective and safe treatment for alopecia areata.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.